Home Featured Page 208

Featured

Latest

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human Psyche

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples Therapy

Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola

The Psychedelic Practitioner Issue 3: Dosing

Red Light Holland Reports Second Quarter 2021 Results

Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans

Albert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing &...

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

Psychedelic Bulletin: Microdosing Study Causes a Stir; COMPASS Secures 5th US...

Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange

Numinus Announces Departure of Stacey Wallin

PTSF86 – Ayahuasca, Chronic Pain, and Legal Psilocybin, with Payton Nyquvest...

Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured...

PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat...

1...207208209...308 Page 208 of 308

EDITOR PICKS

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human Psyche

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples Therapy

Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola

The Psychedelic Practitioner Issue 3: Dosing

Red Light Holland Reports Second Quarter 2021 Results

Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans

Albert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing &...

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

Psychedelic Bulletin: Microdosing Study Causes a Stir; COMPASS Secures 5th US...

Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange

Numinus Announces Departure of Stacey Wallin

PTSF86 – Ayahuasca, Chronic Pain, and Legal Psilocybin, with Payton Nyquvest...

Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured...

PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat...

EDITOR PICKS

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY